
Thursday, March 13, 2025 4:13:49 PM
Any fool who listens to Jim Cramer deserves to lose. Yes, he suckers you in then he goes short. This is well known for many years.
Just my opinion, of course.
Volume: | 15,128 |
Day Range: | 2.05 - 2.18 |
Bid: | 2.07 |
Ask: | 2.11 |
Last Trade Time: | 12:01:58 PM EDT |
Total Trades: | 96 |
Recent SNGX News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/28/2025 08:05:36 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/27/2025 04:15:12 AM
- IBN Initiates Coverage of Soligenix Inc. • GlobeNewswire Inc. • 03/25/2025 12:30:00 PM
- Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants • PR Newswire (US) • 03/25/2025 11:30:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/21/2025 08:09:13 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/21/2025 08:08:19 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/21/2025 08:07:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/21/2025 08:05:31 PM
- Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results • PR Newswire (US) • 03/21/2025 11:30:00 AM
- HyBryte™ Treatment Studies Presented at Two Medical Conferences in March • PR Newswire (US) • 03/06/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2025 12:30:14 PM
- Soligenix to Present at BIO CEO & Investor Conference • PR Newswire (US) • 02/04/2025 12:30:00 PM
- Soligenix to Present at Upcoming Investor Conferences • PR Newswire (US) • 01/16/2025 12:30:00 PM
- HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma • PR Newswire (US) • 01/14/2025 12:30:00 PM
- Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma • PR Newswire (US) • 12/16/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 10:37:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 09:26:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 09:26:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 09:25:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 09:24:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 09:23:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 09:22:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/13/2024 09:20:17 PM
ConnectM Receives $1.60 Per Share Buyout Offer from its Three Largest Institutional Investors • CNTM • Apr 2, 2025 9:00 AM
Nightfood Holdings Completes Acquisition of Carryout Supplies, Deepening Vertical Integration in AI-Powered Hospitality Automation • NGTF • Apr 2, 2025 8:30 AM
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City • AVAI • Apr 2, 2025 8:00 AM
Glidelogic Corp. Unveils ResearchMind - Pioneering AI-Driven Research Innovation for a Global Academic Community • GDLG • Apr 1, 2025 2:10 PM
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks • FITY • Apr 1, 2025 9:30 AM
North Bay Resources Announces Discovery of Mass Tonnage Gold Deposit up to 149m (489 feet) Grading 0.95 g/t Au, Fran Gold Project, British Columbia • NBRI • Apr 1, 2025 9:00 AM